Literature DB >> 32015706

Meta-Analysis: Melatonin for the Treatment of Primary Sleep Disorders.

Eduardo Ferracioli-Oda, Ahmad Qawasmi, Michael H Bloch.   

Abstract

(Reprinted with permission from PLoS ONE, (8)5: e63773, 2013).
Copyright © 2018 by the American Psychiatric Association.

Entities:  

Year:  2018        PMID： 32015706      PMCID： PMC6519571          DOI： 10.1176/appi.focus.16101

Source DB:  PubMed          Journal:  Focus (Am Psychiatr Publ)        ISSN： 1541-4094


  4 in total

Review 1.  Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson's Disease.

Authors:  Santiago Pérez-Lloret; Daniel P Cardinali
Journal:  Front Pharmacol       Date:  2021-04-15       Impact factor: 5.810

2.  Trajectories of Insomnia Symptoms Among Aging Employees and Their Associations With Memory, Learning Ability, and Concentration After Retirement - A Prospective Cohort Study (2000-2017).

Authors:  Antti Etholén; Olli Pietiläinen; Anne Kouvonen; Mirja Hänninen; Ossi Rahkonen; Tea Lallukka
Journal:  J Aging Health       Date:  2022-04-28

Review 3.  Is Melatonin the "Next Vitamin D"?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements.

Authors:  Deanna M Minich; Melanie Henning; Catherine Darley; Mona Fahoum; Corey B Schuler; James Frame
Journal:  Nutrients       Date:  2022-09-22       Impact factor: 6.706

4.  Melatonergic agents influence the sleep-wake and circadian rhythms in healthy and psychiatric participants: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Eunsoo Moon; Timo Partonen; Serge Beaulieu; Outi Linnaranta
Journal:  Neuropsychopharmacology       Date:  2022-02-04       Impact factor: 8.294
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.